We are live on ! Find out more
KA

Kintegral Advisory Portfolio holdings

AUM $1.06B
1-Year Est. Return 24.93%
This Fund
S&P 500
This Quarter Est. Return
+10.75%
1 Year Est. Return
+24.93%
3 Year Est. Return
+94.38%
5 Year Est. Return
+128.14%
10 Year Est. Return
–
AUM
$550M
AUM Growth
+$47.8M
Cap. Flow
-$677K
Cap. Flow %
-0.12%
Top 10 Hldgs %
28.86%
Holding
269
New
1
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$991K
2
TFC icon
Truist Financial
TFC
+$326K
3
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$45K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.72M
2
STI
SunTrust Banks, Inc.
STI
+$320K
3
MMM icon
3M
MMM
+$560

Sector Composition

Rank Sector Weight
1 Technology 27.68%
2 Healthcare 14.72%
3 Financials 13.9%
4 Communication Services 10.73%
5 Consumer Staples 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
251
Regeneron Pharmaceuticals
REGN
$68.8B
$317K 0.06%
845
– –
SJM icon
252
J.M. Smucker
SJM
$12.6B
$308K 0.06%
2,959
– –
EA icon
253
Electronic Arts
EA
$52.4B
$307K 0.06%
2,857
– –
DRI icon
254
Darden Restaurants
DRI
$22.5B
$305K 0.06%
2,800
– –
UDR icon
255
UDR
UDR
$12.9B
$301K 0.05%
6,455
– –
WELL icon
256
Welltower
WELL
$178B
$297K 0.05%
3,627
– –
MAT icon
257
Mattel
MAT
$4.17B
$287K 0.05%
21,159
– –
TSCO icon
258
Tractor Supply
TSCO
$16.3B
$284K 0.05%
15,190
– –
HBI
259
DELISTED
Hanesbrands
HBI
$281K 0.05%
18,920
– –
CHRW icon
260
C.H. Robinson
CHRW
$22B
$276K 0.05%
3,531
– –
VNO icon
261
Vornado Realty Trust
VNO
$7.47B
$272K 0.05%
3,979
– –
WRK
262
DELISTED
WestRock Company
WRK
$272K 0.05%
6,330
– –
VMW
263
DELISTED
VMware, Inc
VMW
$268K 0.05%
1,767
– –
JWN
264
DELISTED
Nordstrom
JWN
$261K 0.05%
6,382
– –
KSS icon
265
Kohl's
KSS
$2.03B
$196K 0.04%
3,853
– –
CVET
266
DELISTED
Covetrus, Inc. Common Stock
CVET
$183K 0.03%
13,865
– –
BMY.RT
267
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$52K 0.01%
+17,299
New +$45K
STI
268
DELISTED
SunTrust Banks, Inc.
STI
– –
-4,648
Closed -$320K
CELG
269
DELISTED
Celgene Corp
CELG
– –
-17,299
Closed -$1.72M
7 8 9 10
11

Similar funds

MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
SFP
Shepherd Financial Partners Winchester, Massachusetts $1.05B AUM 22.07% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.06B AUM 12.86% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $1.05B AUM 17.67% 1-Year Est. Return
LAM
L2 Asset Management Wayland, Massachusetts $1.05B AUM 29.07% 1-Year Est. Return

Kintegral Advisory's Q4 2019 Portfolio in Review

As of Q4 2019, Kintegral Advisory held 269 positions worth $550M, up 9.5% from $502M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 1.1%. Kintegral Advisory opened 1 new position and exited 2, leaving the 269-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • Kintegral Advisory's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 17,299 shares worth $52K.
  • Kintegral Advisory added most to Bristol-Myers Squibb in Q4 2019, an estimated $991K increase.
  • Kintegral Advisory's biggest Q4 2019 reduction was 3M, cutting an estimated $560.
  • Kintegral Advisory fully exited Celgene Corp in Q4 2019, selling an estimated $1.72M.
  • Kintegral Advisory's ten largest holdings make up 29% of its $550M portfolio in Q4 2019.
  • Kintegral Advisory opened 1 new position and closed 2 in Q4 2019.
  • Kintegral Advisory's portfolio value rose 9.5% quarter-over-quarter to $550M.

Based on Kintegral Advisory's 13F filing for Q4 2019, filed 10 Feb 2020.